Tove Abrahamsson is a Researcher and Physician affiliated with Lund University's Psychiatry department, holding a PhD and M.D. She specializes in addiction medicine with a focus on opioid dependence treatment, pharmacology, and clinical interventions. Her work contributes to UN Sustainable Development Goals related to health and well-being. Education includes a Medical Doctorate (M.D.) and a PhD in Psychiatry. Current affiliations include the Clinical Addiction Research Unit and participation in the Malmö Treatment Referral and Intervention Study (MATRIS), a randomized controlled trial addressing opioid dependence treatment pathways. Her research interests center on optimizing addiction treatment strategies, including specialized staff roles in primary care, normative feedback interventions for gambling disorders, and analyzing prescription drug risks in opioid maintenance programs. Notable projects include MATRIS and a national cohort study on benzodiazepine-related mortality risks. Key contributions include peer-reviewed articles on alcohol consultation interventions, gambling behavior longitudinal studies, and buprenorphine treatment efficacy. She collaborates widely in multidisciplinary addiction research networks.
Andrea Kusec serves as a Postdoctoral Research Associate in the Department of Experimental Psychology at the University of Oxford, collaborating with Professor Nele Demeyere on the OX-CHRONIC project investigating long-term cognitive, emotional, and participation outcomes following stroke. Her work bridges neuropsychological research with clinical rehabilitation practice through the Translational Neuropsychology research group. She earned her PhD from the MRC Cognition and Brain Sciences Unit at the University of Cambridge under Dr. Tom Manly, supported by the Gates Cambridge Trust. Her doctoral research developed and tested a novel behavioral intervention for low mood in acquired brain injury through randomized controlled trials delivered both remotely and in person. Dr. Kusec's research centers on the cognition-emotion interface in predicting mental health outcomes after stroke and traumatic brain injury. She employs participatory mixed-methods approaches to develop clinically relevant interventions while centering the experiences of individuals with brain injury. Current priorities include elucidating mechanisms of post-injury mental health difficulties and adapting psychological therapies for cognitive impairments. Analysis of her recent publications reveals three dominant themes: (1) validation of cognitive assessment tools (Oxford Cognitive Screen, Oxford Visual Perception Screen) for stroke survivors; (2) domain-specific relationships between cognitive impairments and mood disorders across recovery phases; (3) development of behavioral activation interventions for low mood in acquired brain injury. Her work consistently emphasizes translational value through remote assessment methods and patient-centered outcomes. Scientific awards: None documented in available sources. Her Gates Cambridge Trust-funded PhD established her research trajectory in intervention development, culminating in the MAPLES randomized controlled trial. Current work is supported by the OX-CHRONIC project grant examining chronic stroke outcomes. She has not supervised any doctoral students but actively collaborates with multidisciplinary stroke rehabilitation teams. As a core member of Oxford's Translational Neuropsychology group, she contributes to developing evidence-based cognitive assessments and mental health interventions for brain injury rehabilitation. Her team emphasizes real-world applicability through remote delivery methods and close partnership with stroke survivor communities.
Timothy Jones is a Clinical Professor at the University of Western Australia (UWA) within the UWA Medical School’s Paediatrics department. He specializes in childhood diabetes and related technologies, focusing on insulin-dependent diabetes mellitus, glycemic control, and automated insulin delivery systems. His research addresses challenges in pediatric diabetes management, including transition care, telehealth integration, and psychosocial outcomes. Key research areas include: Advanced hybrid closed-loop therapy for youth with diabetes Impact of digital technologies on diabetes resilience Automated insulin delivery systems (AID) Hypoglycemia awareness and management Recent articles highlight advancements in diabetes management technologies, emphasizing real-world applications and clinical trial outcomes. His work aligns with UN Sustainable Development Goals related to health and well-being. Grants and projects include: Development of an integrated diabetes data management platform Characterization of hypoglycemia awareness evolution Improving clinical outcomes for young people with type 1 diabetes Validation of physical activity assessment methods in diabetes care Awarded the Research Excellence Award 2022 from the Department of Health (Western Australia), his contributions bridge clinical practice, technology, and public health.
Ying Qing Chen is a Professor of Medicine at the Stanford Prevention Research Center, part of the Department of Medicine at Stanford University. Additionally, she holds an Affiliate Professor position in Biostatistics. Her roles include serving as Director of the Palo Alto Veteran Affairs Cooperative Studies Coordinating Center since 2021. Dr. Chen earned her BS in Mathematics from Peking University (1992) and her PhD in Biostatistics from Johns Hopkins University (1999). Her research focuses on statistical methodologies for HIV/AIDS prevention , including biomarkers, clinical trial design, epidemiological methods, and survival analysis. She also contributes to studies on vaccine effectiveness, adherence to antiretroviral treatments, and the intersection of social stigma with healthcare access in high-risk populations. Her work spans multinational collaborations, such as the HPTN 052, 069/ACTG 5305, and 075 trials, and she leads projects funded by NIH and industry partners (e.g., Sinovac Biotech). Key areas of expertise include evaluating combination prevention strategies, developing statistical surrogacy measures, and analyzing longitudinal clinical data to inform public health policies. Projects: Co-PI for the Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT) study (NIH/NIAID U01 AI163090-01, 2021-Present) PI for Research on Global Vaccine Application and Trends (Sinovac Biotech, 2021-Present) PI/MPI for Ganciclovir to Prevent Cytomegalovirus Reactivation (NIH/NHLBI U24 HL147012, 2020-Present) Dr. Chen’s scientific contributions have been recognized with the Fellowship of the American Statistical Association (2018) . She teaches courses such as Introduction to Clinical Trials: Design, Conduct, and Analysis (CHPR 211) and supervises thesis writing through Community Health and Prevention Research Master's Thesis Writing (CHPR 399). Her research emphasizes improving HIV prevention outcomes, addressing challenges in adherence and combination therapies, and leveraging statistical innovations to enhance vaccine efficacy assessments. She has also demonstrated expertise in handling complex longitudinal datasets and conducting feasibility studies for at-risk populations in sub-Saharan Africa.
Prof. Stefan Berger is a Professor of Internal Medicine and Transplantation Nephrology at the University of Groningen's Faculty of Medical Sciences. He holds leadership roles including Chair of the Department of Internal Medicine and Board Member of the UMCG Comprehensive Transplant Center. His research focuses on kidney and pancreas transplantation, complement immunology, clinical trials, and immunosuppression strategies. Key areas include transplantation outcomes in elderly patients and mechanisms of graft rejection. He leads studies on health-related quality of life in transplant recipients and the impact of lifestyle interventions post-transplantation. Research interests span translational and clinical studies in transplantation immunology, with emphasis on biomarkers (e.g., complement activation, fibrosis markers) and optimizing immunosuppressive protocols. His work also addresses long-term outcomes in kidney transplant recipients, including graft survival, metabolic complications, and infection risks. Recent articles highlight contributions to understanding complement activation in sepsis, cellular mechanisms of antibody-mediated rejection, and the efficacy of exercise/diet interventions on transplant recipient outcomes. Collaborations involve multidisciplinary teams across nephrology, immunology, and clinical epidemiology. Prof. Berger is actively involved in national and international transplant networks, contributing to policy through roles like Chair of the UMCG Transplant Center and leadership in the Dutch Transplant Foundation. His translational research bridges laboratory findings to clinical practice, aiming to improve transplant recipient care and outcomes.
Kazuaki Negishi is a Professor of Medicine and Head of the Discipline of Medicine at Sydney Medical School Nepean, University of Sydney's Faculty of Medicine and Health. He holds adjunct professorships at the University of Tasmania and is a board-certified cardiologist in Japan and Australia. His expertise spans cardio-oncology, air pollution-cardiovascular links, space medicine, and advanced imaging. Clinically, he practices at Nepean Hospital and previously led the Echo lab at Royal Hobart Hospital. He completed his MD and PhD in Japan, with additional training at Cleveland Clinic, USA. Research interests include cardiovascular imaging, subclinical myocardial insults, and health policy. He leads a team of 1 Senior Research Fellow, 2 Post-Doctoral fellows, and supervises PhD students across multiple institutions. Awards include the National Heart Foundation Future Leader Fellowship and international society recognitions (FACC, FESC, FAHA). Key collaborations include NASA, Gunma University (Japan), and the ANZACT Network. His work on SUCCOUR trials and REDUCE trial (sonothrombolysis) aims to improve cardiovascular outcomes in oncology patients. He chairs editorial boards for JACC: Cardiovascular Imaging and Journal of the American Society of Echocardiography .
Dr Amy-Leigh Rowe is a Research Fellow at the Matilda Centre for Research in Mental Health and Substance Use, University of Sydney, within the Faculty of Medicine and Health. She holds a PhD in Psychology from Western Sydney University and specializes in adolescent health, eHealth interventions, and trauma-informed prevention programs. Education: Bachelor of Applied Science (Sport & Exercise), University of Sydney (2011) Bachelor of Psychological Studies (First Class Honours), Western Sydney University (2018) PhD in Psychology, Western Sydney University (2023) Research focuses on preventing substance use and mental health issues in youth through school-based programs like the OurFutures Vaping initiative, now nationwide. She also leads curriculum-aligned healthy relationship education and contributed to NSW Ministry of Health’s youth health policy. Awards : Matilda Centre Awards 2022: Outstanding Contribution (Team) - 2023 School of Psychology Outstanding Engagement Award - 2022 Dean’s Medal for Academic Excellence - 2017 Advising: Supervises Annabelle Hawkins on e-cigarette use trends. Active in grants and policy development, including Makers and Shapers Award (Team) - 2022. Part of the Matilda Centre’s Diversity and Inclusion portfolio and Australian Rotary Health awardee (2024). Labs/Teams: Leads the Matilda Centre’s preventive intervention design and collaborates with the NSW Ministry of Health on youth health initiatives.
Professor Woosung Sohn is Chair of Population Oral Health at the University of Sydney School of Dentistry, where he leads research and teaching in population oral health and collaborates with NSW Health and local health districts. He previously served as Director of the Advanced Specialty Education Program in Dental Public Health and Associate Professor at Boston University Goldman School of Dental Medicine, where he maintains an adjunct appointment. His education includes DDS, MS, and PhD in Preventive Dentistry from Yonsei University, Seoul, Korea, and Doctor of Public Health (DrPH) in Epidemiology from the University of Michigan School of Public Health. He is a Diplomat of the American Board of Dental Public Health. Sohn's research primarily focuses on reducing oral health disparities through understanding factors related to oral disease and improving access to dental care, particularly for underserved populations. His work involves analysis of large datasets including dental claims databases and national surveys, evaluation of state-level oral health policy, and research on children's water consumption patterns related to water fluoridation. His early publications provided key evidence for the 2015 adjustment of USPHS recommendation of optimum fluoride concentration in drinking water to 0.7 ppmF. His recent publications (2023-2025) demonstrate continued focus on health disparities, with particular attention to Indigenous populations in Australia, culturally and linguistically diverse communities, rural health access issues, obesity-related dental care challenges, and antibiotic prescribing patterns in dentistry. His work spans epidemiological studies, policy evaluations, and intervention development. Fellow, ADEA Leadership Institution, American Dental Education Association (2009) IADR Aubrey Sheiham Award for Distinguished Research in Dental Public Health Sciences (2009) Research Fellowship, Oak Ridge Institute for Science and Education (ORISE), CDC (2008) Sohn has directed Advanced Education Programs in Dental Public Health including Residency programs, Masters' in Science (MS), and Doctor of Science in Dentistry (DScD). In 2015, he received a $2.8 million HRSA grant for a combined DPH-Pediatric Dentistry residency training program. He serves as Editor of the Journal of Evidence-Based Dental Practice and on the editorial board of the Journal of Public Health Dentistry. His teaching includes Oral Epidemiology, Dental Public Health, and Evidence-based Dentistry, with a focus on critical thinking and evidence-based practice.
David Glick is a Professor in the Department of Political Science at Boston University, holding positions since 2011. He is the faculty director of MetroBridge, a co-PI of the Menino Survey of Mayors, and a Fellow at multiple institutions including the Office of Evaluation Sciences (GSA) and Brown University’s Policy Lab. He earned his Ph.D. in Politics from Princeton University and previously served as a visiting fellow at Dartmouth College’s Rockefeller Center. His research focuses on American political institutions, courts, local governance, housing policy, and policy diffusion, with a notable book Neighborhood Defenders: Participatory Politics and America’s Housing Crisis . His work has been published in top journals like Nature , PNAS , and American Journal of Political Science . Education: Ph.D., Politics, Princeton University (2010) B.A., Astrophysics and Political Science, Williams College (2002) Research Interests: Glick’s work examines political institutions (especially courts), local policy dynamics, housing crises, and policy diffusion. Recent studies include Zoom’s impact on participatory democracy, vaccination behavior during the pandemic, and mayors’ responses to climate change. His collaborations with Katherine Einstein and Maxwell Palmer on housing policy have gained significant media attention. Key Contributions: Co-authored Neighborhood Defenders (2019), analyzing housing policy coalitions Launched the Menino Survey of Mayors, tracking municipal priorities since 2015 Recipient of prestigious awards including the Heinz Eulau Award and APSA Law and Courts prizes Teaching: Courses include Constitutional Law, Judicial Politics, and a unique class analyzing HBO’s The Wire through a political lens. He pioneered MetroBridge, linking BU courses with real-world municipal projects. Labs/Teams: Active in MetroBridge and the Policy Lab @ Brown, focusing on applied policy research and civic engagement initiatives.
Rachel Brule is an Assistant Professor of Global Development Policy at Boston University’s Pardee School of Global Studies and Core Faculty at the Global Development Policy Center’s Human Capital Initiative. She specializes in comparative politics, international development, and gender studies with a focus on South Asia. Her research examines how political representation impacts social and economic inequality across democratic and hybrid regimes. Brule’s forthcoming book, Women’s Representation and Resistance , explores how women’s political empowerment drives progress in land inheritance rights in India. Brule holds a Ph.D. in Political Science from Stanford University, an M.Sc. from Oxford University, an M.Sc. from the London School of Economics, and a B.A. from Mount Holyoke College. She has conducted fieldwork in India, Africa, and the Middle East, combining randomized controlled trials and survey experiments to study gender quotas, political engagement, and climate resilience. Her work has been recognized with the Pi Sigma Alpha Award (2017), Kellogg Notre Dame Award (2017), Marshall Scholarship, and Truman Scholarship. Her research portfolio includes analyzing climate shocks’ impact on gendered political dynamics in Bangladesh, the effectiveness of multi-dimensional quotas in improving social equality, and the intersectionality of cultural norms and economic disparities in India’s matrilineal tribes. Brule collaborates with institutions like MIT’s Poverty Action Lab and the World Bank, focusing on evidence-based interventions to enhance economic rights and environmental welfare in developing nations.
Cathrine Elgaard Jensen is an Associate Professor in the Department of Clinical Medicine at Aalborg University's Faculty of Medicine. She is affiliated with the Danish Center for Health Services Research and holds a PhD (awarded in 2017). Her research focuses on health economics, public health, and clinical decision-making, with a particular interest in musculoskeletal disorders and quality-of-life assessment. She has led studies on AI-driven clinical decision support systems and geographical health disparities. Her work frequently involves randomized controlled trials and population-level health metrics analysis. Key research themes include healthcare cost-effectiveness, general practice workflows, and the implementation of evidence-based guidelines. Cathrine has contributed to over 38 peer-reviewed publications and 7 datasets, with notable work on AI applications in healthcare and musculoskeletal pain management. Her recent studies explore patient-specific decision support systems and the impact of point-of-care ultrasound in primary care settings.
Rebecca Baelen is a Research Fellow in the Department of Psychology at the University of Illinois Chicago. Her work focuses on mindfulness-based interventions in educational settings, with a particular emphasis on teacher well-being, social-emotional learning (SEL), and youth development. She has contributed to developing scalable mindfulness programs for K-12 educators and students, emphasizing culturally responsive practices and teacher-centered approaches to professional development. Her research also explores leadership frameworks rooted in mindfulness and yoga to improve school culture and organizational change. Key areas of research include: Mindfulness training for educators to enhance social-emotional competencies Optimal program design for youth across developmental stages Teacher resilience through self-compassion interventions Implementation science for school-based programs Her work bridges educational psychology, leadership studies, and contemplative practices, addressing systemic challenges in scaling mindfulness initiatives. Recent studies highlight barriers to student motivation in mindfulness programs and propose innovative solutions for universal school interventions.
Chyrell D. Bellamy, PhD, MSW is Professor of Psychiatry at Yale University's Department of Psychiatry and Director of the Yale Program for Recovery and Community Health (PRCH). She also serves as Director of Peer Support Services & Research and Director of the Yale Lived Experience Transformational Leadership Academy (LET(s)Lead). Additionally, Dr. Bellamy functions as a Senior Policy Adviser for the Office of the Commissioner for the State of Connecticut Department of Mental Health and Addiction Services (DMHAS). Yale School of Medicine, Department of Psychiatry Yale Program for Recovery and Community Health (PRCH) Yale Lived Experience Transformational Leadership Academy (LET(s)Lead) Connecticut Mental Health Center Center for Brain & Mind Health Dr. Bellamy's research expertise centers on community-based participatory research and co-design with communities of color and individuals living with psychiatric illness, substance use disorders, HIV, homelessness, and incarceration histories. Her work focuses on healthcare disparities, sociocultural pathways of recovery, development of culturally responsive interventions, qualitative research methods, and community/clinic-based psychosocial and wellness interventions. She brings personal and professional expertise as a frontline service provider, clinician, social worker, and community organizer, openly identifying as a person with lived experience of multiple marginalized identities including mental illness, trauma, and addictions. Dr. Bellamy's publication record demonstrates significant contributions to mental health equity, with a focus on culturally responsive interventions for marginalized populations. Her research trends show a consistent emphasis on community-driven approaches, particularly through initiatives like Harambee (a wellness intervention for serious mental illness) and Imani Breakthrough (a faith-based opioid recovery program). Her recent publications increasingly incorporate technology and AI considerations in mental healthcare while maintaining strong community engagement principles. The breadth of her work spans from local Connecticut implementations to international collaborations in Brazil. PCORI award for co-located primary care for people with mental illness NIMH R34 award for whole health intervention mechanisms CT DMHAS/SAMHSA State Opioid Recovery funds for Imani Breakthrough program NIH Common Fund/NIDA grant for culturally responsive substance use recovery NIH R34 grant for peer support implementation in Brazil NIH NIMHD grant for Recovery Finance study Dr. Bellamy actively mentors researchers through her leadership roles and directs multiple federally funded research initiatives. Her work with the Yale Program for Recovery and Community Health has secured substantial grant funding from NIH, PCORI, NIMH, and state agencies, focusing on innovative approaches to mental health and substance use recovery. Her research portfolio demonstrates strong community partnerships and a commitment to translating research into practice through programs like LET(s)LEAD, which provides leadership training for people with lived experiences. Dr. Bellamy leads the Yale Program for Recovery and Community Health, which operates through a collaborative network of researchers, community members, and practitioners. Her work with the Lived Experience Transformational Leadership Academy (LET(s)LEAD) represents a significant team-based approach that centers lived experience in research and service delivery. She collaborates extensively with community organizations, particularly faith-based institutions serving Black and Latinx communities, and maintains international partnerships in Brazil for mental health system transformation.
Corey Roos, PhD, is an Assistant Professor of Psychiatry at Yale School of Medicine. His research focuses on developing behavioral and digital mindfulness-based interventions for substance use and eating disorders. He leads the development of the Mindful Journey app for substance use recovery and conducts trials on web-based interventions for relapse prevention. Roos has published over 50 peer-reviewed papers and co-authored a book on mindfulness in psychotherapy. He holds a K23 grant from NCCIH/NIDA for his work on digital mindfulness treatments. Education: PhD in Clinical Psychology from University of New Mexico (2018) Research Interests: Precision medicine, mindfulness therapies, digital health interventions His work emphasizes translating mindfulness practices into scalable treatments, with studies on reward/relief drinking profiles and predictors of eating disorder relapse. Roos mentors Yale postdocs, medical students, and undergraduates in addiction and mindfulness research. Awards: K23 Career Development Grant (NCCIH/NIDA), recognition for work on sleep disturbance in opioid use disorder.
Javier Osorio is an Assistant Professor at the University of Arizona's School of Government and Public Policy. His research focuses on the micro-foundations and dynamics of political and criminal violence in Latin America, employing quantitative methods such as natural language processing, GIS, and big data analytics. He has received awards from the UNODC and MPSA, and his work appears in leading journals like the Journal of Peace Research . Dr. Osorio holds a Ph.D. in Political Science from the University of Notre Dame (2013) and previously taught at John Jay College of Criminal Justice. He leads the Academy for Security Analysis, funded by USAID, and collaborates with the NSF and DoD’s Minerva Initiative. His research projects include supervised event coding for conflict analysis and randomized controlled trials in Central America. His key contributions span conflict language models (e.g., ConfliBERT), criminal violence classification, and multilingual event coding frameworks. He has advised interventions in El Salvador and Nicaragua, emphasizing data-driven approaches to security challenges.
